Monoclonal antibody to ovarian and uterine human cancers

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

167/139, 167/37,

G01N 33/577 (2006.01) C07K 16/30 (2006.01) C12N 5/00 (2006.01)

Patent

CA 1241610

ABSTRACT Mouse monoclonal antibodies to several cell antigens of human ovarian, cervical and endometrial carcinomas have been produced and characterized. The distribution of the antigens was determined by mixed hemagglutination assays on 153 normal and malignant cell cultures of various types, and by immunoperoxidase staining of frozen sections of 27 normal adult and 24 fetal tissues. five monoclonal antibodies representative of five classes of mAb raised to restricted ovarian, cervical and endometrial cells were tested extensively producing mAb reactive with cancer but not normal cells. One such mAb, MF116 was readily detected in the spent culture medium of metabolically radiolabeled cells. These antibodies, reacting with relatively restricted cell surface antigens, are useful in the analysis of epithelial cell differentiation, in cancer diagnosis and therapy and in tissue typing of normal or abnormal cells.

466619

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Monoclonal antibody to ovarian and uterine human cancers does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Monoclonal antibody to ovarian and uterine human cancers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody to ovarian and uterine human cancers will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1321645

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.